Literature DB >> 11447288

IL-7 is critical for homeostatic proliferation and survival of naive T cells.

J T Tan1, E Dudl, E LeRoy, R Murray, J Sprent, K I Weinberg, C D Surh.   

Abstract

In T cell-deficient conditions, naive T cells undergo spontaneous "homeostatic" proliferation in response to contact with self-MHC/peptide ligands. With the aid of an in vitro system, we show here that homeostatic proliferation is also cytokine-dependent. The cytokines IL-4, IL-7, and IL-15 enhanced homeostatic proliferation of naive T cells in vitro. Of these cytokines, only IL-7 was found to be critical; thus, naive T cells underwent homeostatic proliferation in IL-4(-) and IL-15(-) hosts but proliferated minimally in IL-7(-) hosts. In addition to homeostatic proliferation, the prolonged survival of naive T cells requires IL-7. Thus, naïve T cells disappeared gradually over a 1-month period upon adoptive transfer into IL-7(-) hosts. These findings indicate that naive T cells depend on IL-7 for survival and homeostatic proliferation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11447288      PMCID: PMC37504          DOI: 10.1073/pnas.161126098

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  58 in total

1.  Homeostatic expansion and phenotypic conversion of naïve T cells in response to self peptide/MHC ligands.

Authors:  W C Kieper; S C Jameson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

2.  The earliest T lineage-committed cells depend on IL-7 for Bcl-2 expression and normal cell cycle progression.

Authors:  U von Freeden-Jeffry; N Solvason; M Howard; R Murray
Journal:  Immunity       Date:  1997-07       Impact factor: 31.745

3.  Persistence of memory CD8 T cells in MHC class I-deficient mice.

Authors:  K Murali-Krishna; L L Lau; S Sambhara; F Lemonnier; J Altman; R Ahmed
Journal:  Science       Date:  1999-11-12       Impact factor: 47.728

4.  TCR-MHC class II interaction is required for peripheral expansion of CD4 cells in a T cell-deficient host.

Authors:  U Beutner; H R MacDonald
Journal:  Int Immunol       Date:  1998-03       Impact factor: 4.823

5.  Differential requirements for survival and proliferation of CD8 naïve or memory T cells.

Authors:  C Tanchot; F A Lemonnier; B Pérarnau; A A Freitas; B Rocha
Journal:  Science       Date:  1997-06-27       Impact factor: 47.728

6.  Targeted complementation of MHC class II deficiency by intrathymic delivery of recombinant adenoviruses.

Authors:  R Rooke; C Waltzinger; C Benoist; D Mathis
Journal:  Immunity       Date:  1997-07       Impact factor: 31.745

7.  Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice.

Authors:  K Akashi; M Kondo; U von Freeden-Jeffry; R Murray; I L Weissman
Journal:  Cell       Date:  1997-06-27       Impact factor: 41.582

Review 8.  The interleukin-2 receptor gamma chain: its role in the multiple cytokine receptor complexes and T cell development in XSCID.

Authors:  K Sugamura; H Asao; M Kondo; N Tanaka; N Ishii; K Ohbo; M Nakamura; T Takeshita
Journal:  Annu Rev Immunol       Date:  1996       Impact factor: 28.527

9.  Impaired survival and proliferation in IL-7 receptor-deficient peripheral T cells.

Authors:  E Maraskovsky; M Teepe; P J Morrissey; S Braddy; R E Miller; D H Lynch; J J Peschon
Journal:  J Immunol       Date:  1996-12-15       Impact factor: 5.422

10.  Interleukin 4 (IL-4) or IL-7 prevents the death of resting T cells: stat6 is probably not required for the effect of IL-4.

Authors:  A Vella; T K Teague; J Ihle; J Kappler; P Marrack
Journal:  J Exp Med       Date:  1997-07-21       Impact factor: 14.307

View more
  390 in total

1.  Homeostatic T cell proliferation in a T cell-dendritic cell coculture system.

Authors:  Qing Ge; Deborah Palliser; Herman N Eisen; Jianzhu Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-19       Impact factor: 11.205

Review 2.  Qualitative differences between naïve and memory T cells.

Authors:  Marion Berard; David F Tough
Journal:  Immunology       Date:  2002-06       Impact factor: 7.397

3.  T cells take aim at cancer.

Authors:  Drew Pardoll
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-02       Impact factor: 11.205

4.  Naive human T cells are activated and proliferate in response to the heme oxygenase-1 inhibitor tin mesoporphyrin.

Authors:  Trevor D Burt; Lillian Seu; Jeffrey E Mold; Attallah Kappas; Joseph M McCune
Journal:  J Immunol       Date:  2010-10-04       Impact factor: 5.422

5.  Both exogenous commensal and endogenous self antigens stimulate T cell proliferation under lymphopenic conditions.

Authors:  Jeong-su Do; Gilles Foucras; Nobuhiko Kamada; Austin F Schenk; Michael Shaw; Gabriel Nuñez; William E Paul; Booki Min
Journal:  Cell Immunol       Date:  2011-11-25       Impact factor: 4.868

Review 6.  Concise review: engineering the fusion of cytokines for the modulation of immune cellular responses in cancer and autoimmune disorders.

Authors:  Spencer Ng; Jacques Galipeau
Journal:  Stem Cells Transl Med       Date:  2014-11-12       Impact factor: 6.940

Review 7.  Interlinking interleukin-7.

Authors:  Christina Kittipatarin; Annette R Khaled
Journal:  Cytokine       Date:  2007-09-04       Impact factor: 3.861

8.  Quantifying the development of the peripheral naive CD4+ T-cell pool in humans.

Authors:  Iren Bains; Rustom Antia; Robin Callard; Andrew J Yates
Journal:  Blood       Date:  2009-01-28       Impact factor: 22.113

9.  HVEM Imprints Memory Potential on Effector CD8 T Cells Required for Protective Mucosal Immunity.

Authors:  Pritesh Desai; Georges Abboud; Jessica Stanfield; Paul G Thomas; Jianxun Song; Carl F Ware; Michael Croft; Shahram Salek-Ardakani
Journal:  J Immunol       Date:  2017-09-01       Impact factor: 5.422

10.  Interleukin-7 receptor signaling is deficient in CD4+ T cells from HIV-infected persons and is inversely associated with aging.

Authors:  Douglas A Bazdar; Magdalena Kalinowska; Scott F Sieg
Journal:  J Infect Dis       Date:  2009-04-01       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.